Physician
General Surgery
Dr. David Z. Chu, MD
|
|
Give Review
David practices General Surgery. He attended David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical college. David Geffen School of Medicine at UCLA is ranked 13 in research and 7 in primary care medicine He over the years received 2 awards: "Top Doctors:LA Area" and "Fellow (FACS)". David Z. Chu, MD is a published doctor as well. He has 57 publications published. The latest was: Resection with external beam and intraoperative radiotherapy for recurrent colon cancer.
Publications
- Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic Cancer: a United States population-based assessment.
- A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing Malignancies.
- Clear cell Sarcoma in the era of sentinel lymph node mapping.
- Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with coloRectal cancer.
- A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic coloRectal cancer.
- Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-Analysis.
- Necrotizing gas-forming infections in Cancer patients.
- Aromatic amine acetyltransferase as a marker for coloRectal cancer: environmental and demographic associations.
- Immunosuppression in patients with metastatic squamous cell Carcinoma from the skin.
- Purpura fulminans.
- Role of aromatic amine acetyltransferase in human coloRectal cancer.
- Regional chemotherapy of liver metastases from coloRectal carcinoma: hepatic artery or portal vein infusion?
- Peritoneal Carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors.
- When is polypectomy sufficient treatment for coloRectal cancer in a polyp?
- Prognostic significance of carcinoembryonic antigen in coloRectal carcinoma. Serum levels before and after resection and before recurrence.
- Proton NMR of human Breast tumors: correlation with clinical prognostic parameters.
- Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients.
- A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignanc...
- Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical coloRectal cancer patients.
- Surgical palliation at a Cancer center: incidence and outcomes.
- CEA for monitoring colon Cancer.
- The significance of synchronous Carcinoma and polyps in the colon and rectum.
- Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.
- Revision and psychometric testing of the City of Hope Quality of Life-Ostomy Questionnaire.
- Esthetic reconstruction after mastectomy for inflammatory breast Cancer: is it worthwhile?
- Beyond palliative mastectomy in inflammatory breast Cancer--a reassessment of margin status.
- Indications and use of palliative surgery-results of Society of Surgical Oncology survey.
- Survey of physicians' attitudes relative to the field of surgical oncology.
- Ethnic differences in the behavior of hepatocellular Carcinoma.
- Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast Cancer.
- Resection with external beam and intraoperative radiotherapy for recurrent colon Cancer.
- Local recurrence in breast Cancer: implications for systemic disease.
- Phase I trial of intraperitoneal gemcitabine in the treatment of advanced Malignancies primarily confined to the peritoneal cavity.
- Phase I trial of intraperitoneal docetaxel in the treatment of advanced Malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacoki...
- Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological Cancer.
- The role of pelvic exenteration in the management of recurrent Rectal cancer.
- Online exclusive: patient and surgeon decision making regarding surgery for advanced Cancer.
- Concerns of family caregivers of patients with Cancer facing palliative surgery for advanced malignancies.
- The surgical treatment of Cancer: a comparison of resource utilization following procedures performed with a curative and palliative intent.
- Adenoma recurrences after resection of coloRectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study.
- A prospective evaluation of palliative outcomes for surgery of advanced Malignancies.
- Quality of life in patients with coloRectal metastasis and intrahepatic chemotherapy.
- Impact of intraoperative radiation on postoperative and disease-specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score Analysis.
- Decision making in palliative surgery.
- Intraoperative radiation therapy for patients with recurrent Rectal and sigmoid colon cancer in previously irradiated fields.
- Long-term survival after radical operations for Cancer treatment-induced sarcomas: how two survivors invite reflection on oncologic treatment concepts.
- Current surgical options in the control of cancer Pain.
- Evaluation of quality of life (QOL) in pancreaticoduodenectomy survivors.
- Re: Breast Cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
- Cancer recurrence and survival associated with dietary patterns in stage III colon Cancer.
- The surgeon's role in cancer prevention. The model in coloRectal carcinoma.
- Clinicopathologic significance of synchronous and metachronous adenomas in coloRectal cancer.
- Unaccounted breast Cancers do not infer regression of tumors.
- Quality of care review: some progress, and toward what goal?
- Future of surgery: accountable care organizations and the end of private practice?
- ColoRectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
University Of California San Diego
University Of California Davis
MD Anderson Hospital
Procedures Preformed
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Biopsy of Breast
- Colectomy
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- AnoRectal Abscess
- Appendicitis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Top Doctors:LA Area
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
University of California Davis -
University of California San Diego -
David Geffen School of Medicine at UCLA
Hospital
-
Santa Clara Valley Medical Center -
Huntington Memorial Hospital
Drug Facts
| NPI NUMBER | 1477553485 | |
| NPPES Provider LastName | CHU | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 917761236 | |
| NPPES Provider State | CA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 74.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477553485 |
| Last Name Of The Provider | CHU |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. David T. Fang, MD |
|
|
Dr. Tin T. Htwe, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Z. Chu, OD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phoenix Vuong, MD |